“There is a day coming where everyone on the planet will be touched by SOSV companies, every day,” SOSV Managing General Partner Sean O’Sullivan said in his opening remarks at the top of SOSV’s 2023 Annual General Meeting in New York City on June 1. “It’ll be in the clothes they wear, the food they eat, the energy that powers their day, and the decarbonized atmosphere that our companies produce for a more sustainable planet.”
On that exciting note, SOSV convened the annual gathering of SOSV limited partners at our new 7 Penn Plaza office. SOSV general partners Sean O’Sullivan and Stephen McCann provided updates on SOSV’s funds. HAX managing director Duncan Turner and IndieBio managing directors Po Bronson and Stephen Chambers walked through their programs and also delved into exciting developments in SOSV’s climate and health portfolios.
Two SOSV portfolio founders also took the stage: Unspun’s Kevin Martin (HAX) discussed clothing maker’s recent $14M Series A and Vega, Unspun’s revolutionary new 3D weaving technology, and Ten63 Therapeutics’ Marcel Frenkel (IndieBio) addressed the firm’s BEYOND platform, which “combines physics and AI in hyper-efficient search algorithms” to push the boundaries of computational drug discovery.
